To: Sir Auric Goldfinger who wrote (2621 ) 10/14/2000 9:48:03 AM From: DanZ Read Replies (1) | Respond to Plenty of small companies don't have coverage by big firms until they do something to get analysts interested. The company is talking to analysts, and in fact, several fund managers and analysts contacted Gum Tech after the three new Board members were announced a few weeks ago. Do you think that one or more of the analysts that follow VPHM might cover GUMM if/when the preventative clinical study comes back positive? How about the analysts that cover SWMAY? Any other analysts might be interested when they get a better idea of what Gum Tech is doing? Is it reasonable to conclude that analysts will never cover GUMM just because they don't cover them now? No, I didn't think so.
